Skip to main content

Michael B. Drazin

Equibles does not estimate personal net worth.

Get an email with a short summary when Medline Inc. publishes a filing, an earnings call transcript or a press release.

Get MDLN alerts

About Michael B. Drazin

Michael B. Drazin is recorded as CFO at Medline Inc. (MDLN). The newest filing on record that lists Michael B. Drazin as CFO at Medline Inc. (MDLN) is dated April 23, 2026. Michael B. Drazin has spoken on 3 earnings calls and 4 other investor events across 1 company, most recently for Medline Inc. on September 15, 2026. Medline Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Medline Inc. includes James M. Boyle (CEO and Board Member) and Todd M. Bluedorn (Board Member).

Michael B. Drazin on recent calls

“The quarter was really strong, top-line growth of about 11.6% on a reported basis. If you actually adjusted out the impact from the tariff refunds, customer repayments, we actually grew close to 13%.”
CFO, Morgan Stanley 24th Annual Global Healthcare Conference ·
“Before walking through the results, I want to thank our employees, particularly the TRACIE teams, distribution team members across the network, and everyone who supported our California customers for their extraordinary effort and commitment this quarter.”
CFO, Medline Second Quarter 2026 Results Conference Call ·
“We had organic growth of about 10%, oral growth of about 11%. That's not adjusted for days. So if you adjusted for days, our actual growth is closer to 13%. So really pleased with the demand across all of our businesses.”
CFO, Goldman Sachs 47th Annual Global Healthcare Conference ·
“Talk to us about what Medline is and give a little bit of, I think what's interesting here too, is that you have a very long history of building this company, what it is today what do you do and what was it about maybe needing to be a private company for so long to get to where you can to to do what you do today so so…”
CFO, William Blair 46th Annual Growth Stock Conference ·
“We had a strong start to the year with the first quarter net sales of $7.4 billion, up 11% versus prior year. The majority of our growth was organic, with minimal contribution from foreign currency changes.”
CFO, Medline Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Medline Inc. (MDLN)

    CFO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 23, 2026

Company network

Leadership on record at Medline Inc.

Recent activity